Hepatoprotective Effect of Majonoside R₂, the Major Saponin from Vietnamese Ginseng (Panax vietnamensis)

Abstract

The hepatoprotective effect of majonoside R₂ (MR2), the major saponin constituent from Vietnamese ginseng (Panax vietnamensis, Araliaceae), was evaluated in vivo on D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-induced hepatic apoptosis and subsequent liver failure in mice. Pretreatment of mice with MR2 (50 or 10 mg/kg, intraperitoneal) at 12 and 1 h before D-GalN/LPS injection significantly inhibited apoptosis and suppressed following hepatic necrosis. Importantly, the elevation of serum tumor necrosis factor-alpha (TNF-α) level, an important mediator for apoptosis in this model, was significantly inhibited by MR2 at a dose of 50 mg/kg. On the other hand, MR2 was found to protect primary cultured mouse hepatocytes from cell death by inhibiting apoptosis induced by D-GalN/TNF-α in vitro, as evidenced by DNA fragmentation analysis. These findings suggested that MR2 may have protected the hepatocytes from apoptosis via an inhibition of TNF-α production by activated macrophages and a direct inhibition of apoptosis induced by TNF-α.

Panax vietnamensis - Araliaceae - hepatoprotective effect - apoptosis - Vietnamese ginseng - majonoside R₂

References

• 1 Tran Q L, Adnyana I K, Tezuka Y, Nagaoka T, Tran Q K, Kadota S. Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity.  Journal of Natural Products. 2001;  64 456-61
• 2 Hikino H, Kiso Y, Kinouchi J, Sanada S, Shoji J. Antihepatotoxic actions of ginsenosides from Panax ginseng roots.  Planta Medica. 1985;  57 62-4
• 3 Liu J, Liu Y, Klaassen C D. The effect of Chinese hepatoprotective medicines on experimental liver injury in mice.  Journal of Ethnopharmacology. 1994;  42 183-91
• 4 Prasain J K, Kadota S, Basnet P, Hase K, Namba T. Hepatoprotective effects of Panax notoginseng: Ginsenosides Re and Rg₁ as its active constituents in D-galactosamine/lipopolysaccharide-induced liver injury.  Phytomedicine. 1996;  2 297-303
• 5 Nguyen T D, Villard P H, Barlatier A, Elsisi A E, Jouve E, Duc N M, Sauze C, Durand A, Lacarelle B. Panax vietnamensis protects mice against carbon tetrachloride-induced hepatotoxicity without any modification of CYP2E1 gene expression.  Planta Medica. 2000;  66 714-9
• 6 Tiegs G. Immunotoxicology of host-response-mediated experimental liver injury.  Journal of Hepatology. 1994;  21 890-903
• 7 Xiong Q, Hase K, Tezuka Y, Namba T, Kadota S. Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury.  Life Science. 1999;  65 421-30
• 8 Adnyana I K, Tezuka Y, Banskota A H, Xiong Q, Tran K Q, Kadota S. Hepatoprotective constituents of the seeds of Combretum quadrangulare .  Biological Pharmaceutical Bulletin. 2000;  23 1328-32
• 9 Ram V J, Goel A. Present status of hepatoprotectants. In: Jucker E, editor Progress in Drug Research. Vol. 52. Basel (Switzerland); Birkhauser Verlag 1999: 53-101
• 10 Seglen P O. Preparation of isolated rat liver cells.  Methods in Cell Biology. 1976;  13 29-83
• 11 Bradham C A, Plumpe J, Manns M P, Brenner D A, Trautwein C. Mechanism of hepatic toxicity I. TNF-induced liver injury.  American Journal of Pyhsiology. 1998;  275 G387-92
• 12 Leist M, Gantner F, Bohlinger I, Tiegs G, Germann P G, Wendel A. TNF-induced hepatocytes apoptosis precedes liver failure in experimental murine shock models.  American Journal of Pathology. 1995;  146 1220-34
• 13 Martich G D, Danner R L, Ceska M, Suffredini A F. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of anti-inflammatory agents.  Journal of Experimental Medicines. 1991;  173 1021-4
• 14 Tracey K J, Fong Y, Hesse D G, Manogue K R, Lee A T, Kuo G C, Lowry S F, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.  Nature. 1987;  330 662-4
• 15 Czaja M J, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor.  Gastroenterology. 1995;  108 1849-54
• 16 Leist M, Gantner F, Naumann H, Bluethmann H, Vogt K, Brigelius-Flohe R, Nicotera P, Volk H D, Wendel A. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins.  Gastroenterology. 1997;  112 923-4
• 17 Iimuro Y, Galluci R M, Luster M I, Kono H, Thurman R G. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.  Hepatology. 1997;  26 1530-7
• 18 Kuzuhara H, Nishiyama S, Minowa N, Sasaki K, Omoto S. Protective effect of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model.  European Journal of Pharmacology. 2000;  391 175-81
• 19 Kawaguchi K, Kikuchi S, Hasegawa H, Maruyama H, Morita H, Kumazawa Y. Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by narigin.  European Journal of Pharmacology. 1999;  368 245-50
• 20 Nowak M, Gaines G C, Rosenberg J, Minter R, Bahjat F R, Rectenwald J, MacKay S LD, Edwards III C K, Moldawer L L. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor.  American Journal of Physiology. 2000;  278 R1202-9
• 21 Jones B, Lo C R, Liu H, Srinivasan A, Streetz K, Valentino K L, Czaja M J. Hepatocytes sensitized to TNF-α cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways.  Journal of Biological Chemistry. 2000;  275 705-12
• 22 Chosay J G, Essani N A, Dunn C J, Jaeschke H. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury.  American Journal of Physiology. 1997;  272 G1195-200